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Abstract
Chronic Schistosoma infection is often characterized by a state of T cell hyporesponsiveness of the host. Suppression of
dendritic cell (DC) function could be one of the mechanisms underlying this phenomenon, since Schistosoma antigens are
potent modulators of dendritic cell function in vitro. Yet, it remains to be established whether DC function is modulated
during chronic human Schistosoma infection in vivo. To address this question, the effect of Schistosoma haematobium
infection on the function of human blood DC was evaluated. We found that plasmacytoid (pDC) and myeloid DC (mDC)
from infected subjects were present at lower frequencies in peripheral blood and that mDC displayed lower expression
levels of HLA-DR compared to those from uninfected individuals. Furthermore, mDC from infected subjects, but not pDC,
were found to have a reduced capacity to respond to TLR ligands, as determined by MAPK signaling, cytokine production
and expression of maturation markers. Moreover, the T cell activating capacity of TLR-matured mDC from infected subjects
was lower, likely as a result of reduced HLA-DR expression. Collectively these data show that S. haematobium infection is
associated with functional impairment of human DC function in vivo and provide new insights into the underlying
mechanisms of T cell hyporesponsiveness during chronic schistosomiasis.
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Introduction
Chronic parasitic helminth infections are generally associated
with a T helper 2 (Th2)-like immunological profile as well as
immune hyporesponsiveness [1,2]. The latter characteristic is
probably the result of immune evasion strategies that these
pathogens have developed to ensure long term survival within
their hosts and to allow continued transmission. Also chronic
infections with blood-dwelling trematodes of the genus Schistosoma
are well known for their capacity to suppress immune responses,
which is not only reflected in negative regulation of parasite
specific immune responses but also by attenuation of effector
responses to third party antigens, including allergens [3–5], and
other pathogens [6,7].
Dendritic cells (DC) are the most important antigen presenting
cells (APC) that initiate immune responses and as such play a
central role in the development and regulation of protective
immunity against invading pathogens as well as tolerance under
homeostatic conditions [8,9]. In peripheral blood, two major DC
subsets can be identified: the CD11c
+ myeloid DC (mDC) and
CD123
+ plasmacytoid DC (pDC) [10]. Both are immature DC
that are in the process of migration to their target sites. It is
believed that these subsets perform different functions in both
innate and adaptive immune responses. Human mDC express
Toll-like receptors (TLR)-2, -4 and -8 and are thought to
preferentially induce T cell responses to invading pathogens. On
the other hand, human pDC have a different but complementary
TLR expression profile that includes TLR-7 and -9 and are
believed to play an important role in innate anti-viral responses as
well as in induction of tolerance against self-antigens [11,12].
One of the main characteristics of immune hyporesponsivess
during chronic schistosomiasis is the impairment of effector T cell
responses, a process in which T cell anergy and regulatory T cells
have been proposed to play an important role [13,14]. Given that
DC are central players in the priming and regulation of T cell
responses, suppression of these host immune responses by
schistosomes through modulation of DC function would seem
plausible. Indeed, studies have demonstrated that host derived
anti-inflammatory mediators, such as IL-10 [15], which is elevated
during chronic schistosomiasis [5,16,17], as well as Schistosoma-
derived molecules [18,19] have the potential to modulate DC
function and its T cell priming capacity in vitro. However, it
remains to be established whether human DC function is actually
modulated in vivo during chronic schistosomiasis.
To address this question, we evaluated the function of blood DC
in a cross-sectional study in Gabon, a region endemic for
Schistosoma haematobium [5]. We find that mDC isolated from
infected subjects have an impaired capacity to respond to TLR
ligands and to prime T cell responses. In addition, our data
indicate that the former observation is due to a dampened pro-
inflammatory signaling rather than lower TLR expression, and
that the latter finding originates from a reduced expression of
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blood mDC during chronic S. haematobium infection and shed new
light on the mechanisms underlying immune hyporesponsivess
during chronic helminth infections.
Materials and Methods
Ethics statement
The study was approved by the Comite ´ d’Ethique Re ´gional
Independent de Lambare ´ne ´ (CERIL). Written informed consent
was obtained from all subjects participating in the study.
Study population
Venous blood was obtained from 43 young adults (mean age
25,365,8 years) living in or in the vicinity of Lambare ´ne ´, Gabon, a
semi-urban municipality and an area in which Schistosoma
haematobium infection is endemic [5]. Infection with S. haematobium
was determined by passing 10 ml urine through 12 mm diameter
filter. From every subject two independent urine screenings were
performed to increase accuracy. The subjects were grouped into
an infected group and non-infected group, which were sex and age
matched. Furthermore, subjects were screened for other parasitic
blood infections, including malaria and filariasis, as determined by
microscopic analysis of Giemsa-stained blood smears (Table 1).
For HLA-DR and/or CD80 neutralization experiments in the
DC-T cell cocultures, mDC were isolated from venous blood from
healthy European subjects.
Blood DC isolation
PBMCs were isolated by Ficoll-Hypaque density gradient
centrifugation from 40 ml of heparinized venous blood. Myeloid
DC (mDC; BDCA-1+) were isolated by CD19-negative selection,
followed by CD1c-positive selection using MACS and BDCA-1
Dendritic Cell Isolation Kit (Miltenyi Biotec). Subsequently, to
maximize cell yield plasmacytoid DC (pDC; BDCA4
+/CD123
+)
were isolated from the flowthrough of the mDC isolation by using
and BDCA-4 Dendritic Cell Isolation Kit (Miltenyi Biotec). Purity
based on BDCA-1/CD11c and BDCA-4/CD123 expression for
myeloid and plasmacytoid DCs, respectively, was routinely more
than 90%.
Characterization of DC populations in peripheral blood
For immunophenotyping and determination of frequencies of
mDC and pDC present in peripheral blood, part of freshly isolated
PBMCs were fixed using a ‘fixation and dead cell discrimination
kit’ (Miltenyi Biotec), according to the manufacturers recommen-
dations. Subsequently, cells were washed in 0,5%BSA/PBS and
stained for 30 minutes at 4uC with anti-CD19-Pacific blue
(Biolegend), anti-CD14-Pacific blue (Biolegend), anti-HLA-DR-
APC/cy7 (Biolegend), anti-BDCA-1-APC (Miltenyi Biotec) and
anti-BDCA-2-biotin/streptavidin-Qdot526 (both eBioscience) in
combination with either anti-CD80-PE/Cy5 (BD) and anti-TLR4-
FITC (BD) or anti-CD86-FITC (BD) and anti-CCR7-PE/Cy7
(BD). As gating strategy, blood DC were selected as the CD14
2/
CD19
2/HLA-DR
+ population, followed by gating on BDCA-1
and BDCA-2 positive cells as selective markers for mDC and
pDC, respectively. Frequencies as well as expression levels of
TLR4, CD80, CD86, HLA-DR, CCR7 on these subpopulations
were determined.
Blood DC culture
Freshly isolated DC (2610
4 cells/well in 200 ml) were cultured
in complete RPMI 1640 medium containing 10% FCS, 100 U/ml
penicillin, and 100 mg/ml streptomycin and supplemented with
500 U/ml GM-CSF or 10 ng/m IL-3 (both Strathmann,
Germany) for mDC and pDC respectively. DC were stimulated
with 100 ng/ml LPS (ultrapure, E. coli 0111 B4 strain), 1 mg/ml
Author Summary
A key feature of schistosomiasis, as well as of other
systemic helminth infections, is their chronic nature. This
reflects the successful evasion and suppression of host
immune responses by the parasites. One of the mecha-
nisms that could underlie this phenomenon is modulation
of the dendritic cells (DC), which play a central role in
initiation and control of T cell responses. Although several
in vitro studies have documented the modulatory
capacity of Schistosoma antigens on DC function, it is
still unclear what effect schistosomiasis has on human DC
function in vivo. To address this question, we isolated the
two main DC subsets present in peripheral blood from
infected and uninfected individuals living in a Schistoso-
ma-endemic area in central Africa, and found that
specifically the myeloid DC from Schistosoma-infected
subjects displayed an impaired capacity to respond to
Toll-like receptor ligands and to drive T cell responses.
These findings provide new insights into how schistoso-
miasis suppresses host immune responses, which can be
exploited for new strategies to enhance immunity against
the parasites.
Table 1. Study population.
S. haematobium infected n=23 Uninfected n=20 p value
Area Gabon, Lambare ´ne ´ & vicinity Gabon, Lambare ´ne ´
Male/female 17/6 17/3 0.71
¤
Mean age in years (range) 25.2 (17–39) 27.2 (20–37) 0.27
Mean egg counts (range)
D 267 (1–5000) 0 ND
Subjects with co-infection
Malaria* 1 0 ND
Microfilaria*
,# 11 5 0.22
¤
D, based eggs present in 10 ml urine trapped by a 12 mm filter; *, based on Giemsa-stained whole blood smear;
#, based on presence of microfilaria in cell cultures;
¤,X
2
analysis with Fisher’s exact test; ND, not determined.
doi:10.1371/journal.pntd.0000667.t001
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supernatants and cells were harvested. For analysis of surface
marker expression of TLR stimulated DC, the cells were fixed in
2% formaldehyde (Sigma-Aldrich) for 15 minutes and, after two
washing steps in 0,5%BSA/PBS, stained for 30 minutes at 4uC
with a combination of either anti-HLA-DR-PerCP, anti-CD80-
PE, anti-CD86-FITC and anti-CD40-APC or anti-PD-L1-APC,
anti-ICOS-L-PE and anti-CCR7-FITC (all BD).
MAPK assay
Freshly isolated DCs (2610
4 cells/well in 200 ml) were seeded to
rest for 24 h in 96-well round bottom plates before stimulation
with LPS. After 20 or 60 minutes cells were fixed for 10 minutes
with 4% ultrapure formaldehyde (Polysciences) directly in the
plate. Cells were harvested and washed twice in PBS/0.5% BSA.
Subsequently, the DCs were permeabilized in 700 ml ice-cold 90%
methanol in PBS and stored at 280uC until analysis. For
intracellular staining of phosphorylated MAPK, fixed permeabi-
lized DC were washed twice in PBS/0.5%BSA and subsequently
stained with anti-phospho-p44/42 MAPK AF-488 (T202/Y204)
and anti-phospho-p38 MAPK AF-647 (T180/Y182), (both Cell
Signalling Technology) for 2 hours at room temperature in the
dark.
mDC coculture with naive T helper cells
5610
3 LPS-matured mDC were cocultured with 2610
4
allogeneic naive T helper cells in 96-well flat-bottom plates in
200 ml (Corning). Naive T helper cells were purified from a single
European donor using the human CD4+/CD45RO- column kit
(R&D, Minneapolis, MN). In some experiments cocultures were
performed in the presence of 10 mg/ml IgG1, blocking mAbs
against HLA-DR (varying concentrations, clone L243, Biolegend)
or CD80 (5 mg/ml, clone 37711) (both R&D systems). After 6 days
supernatants were harvested for determination of cytokine levels.
In addition, T cells were counted with a counting chamber. For
intracellular cytokine analysis T cells were restimulated with
200 ng/ml PMA and 2 mg/ml ionomycin in the presence of
10 mg/ml brefeldin A (all Sigma-Aldrich) during 6 h, followed by
fixation in 4% formaldehyde (Sigma-Alldrich) for 15 minutes at
RT. After washing in 0.5% saponin/PBS, T cells were stained for
30 minutes in 0.5% saponin/PBS with anti-IL4-PE, anti-IFNc-
FITC, anti-TNF-a-biotin, anti-IL-10-APC (all BD Biosciences)
followed by a second incubation with streptavidin-PerCP
(eBioscience) at RT. In addition, T cells were stained for activation
markers CD25-APC and HLA-DR-FITC (both BD).
Cytokine analysis
Cytokine levels in supernatants from 40 h stimulated DC and
6 d T cells cultures were determined using Luminex-100
cytometer (Luminex Corporation, TX, USA). DC supernatants
were analysed simultaneously for IL-1b, IL-6, IL-10, IL-12, TNF-
a and IFN-a, while in T cell supernatants levels of IL-10, TNF-a,
IL-4, IL-5, IL-13 and IFN-c were determined. Buffer reagent and
Luminex cytokine kits (Biosource, CA, USA) for cytokine analysis
were used according to the manufacturers’ recommendations.
Samples with concentrations below the detection limit, as
determined by the provided standards, were given half the value
of this threshold.
Flow cytometric analysis
FACS experiments were performed on a Becton Dickinson
FACSCalibur flowcytometer (BD) with CellQuest software (BD),
except for the direct characterization of blood DCs in PBMCs,
which was performed on a FACSCanto II (BD) using FACSDiva
software. For the latter analysis, Fluoresence-minus-one (FMOs)
was taken along as controls. FACS data were analysed using
FlowJO software (Treestar, USA).
Statistical analysis
Data were analysed using SPSS (v14.0) and GraphPad Prism
(v5). For multiple comparisons, the Kruskal-Wallis H nonpara-
metric test was applied. Statistical difference between two groups
was determined by applying the Mann-Whitney U nonparametric
test. A paired t test was used to show the effect of treatment with
specific blocking or stimulating abs on T cell function. Differences
were considered significant when P-values were below 0.05.
Results
S. haematobium infected subjects have lower frequencies
of mDC and pDC in peripheral blood
To study the effect of S. haematobium infection on human
dendritic cell phenotype and function, we characterized the two
major dendritic cell subsets present in peripheral blood, CD11c/
BDCA1
+ myeloid DC (mDC) and CD123
+/BDCA2
+ plasmacy-
toid DC (pDC) [11], in 23 infected and 20 uninfected individuals
recruited from a S. haematobium endemic area in Gabon (for
characteristics of the study population, see Table 1). The
frequencies of mDC and pDC were determined in peripheral
blood mononuclear cells (PBMC) isolated from infected and
uninfected subjects, by gating on HLA-DR
+/BDCA1
+/CD14
2/
CD19
2 and HLA-DR
+/BDCA2
+/CD14
2/CD19
2 populations,
respectively (Fig. 1A). Both mDC and pDC frequencies were
significantly reduced in the infected group compared to the
uninfected subjects (Fig. 1B). Of note, the infected individuals were
found to have higher PBMC counts (1.64*10
6/ml 60.13)
compared to the uninfected subjects (1.26*10
6/ml 60.11)
(p=0,04). Nonetheless, the absolute numbers of both pDC and
mDC/ml blood were still lower in the infected individuals
compared to the uninfected individuals (pDC from infected:
0.37*10
4/ml 60.04 versus uninfected 0.61*10
4/ml blood 60.11,
p=0,02, and mDC from infected: 0.66*10
4/ml blood 60.06
versus uninfected: 1.05*10
4/ml 60.16, p=0,01). In addition, to
determine whether the activation status of the DC subsets differs
between infected and uninfected subjects surface expression of
HLA-DR, CD80, CD86, CD40 and CCR7 was analysed. In
particular HLA-DR expression on mDC was significantly lower in
the infected subjects (Fig. 1C), indicating that mDC are
phenotypically different during infection. The expression of the
other markers was not different between the groups.
mDC, but not pDC, from S. haematobium infected
subjects have reduced responses to TLR ligands
Schistosomal antigens have been shown to harbour the capacity
to modulate and suppress TLR-induced activation of in vitro
generated DC [18–20]. To address whether TLR-mediated
activation of human blood DC during Schistosoma infection is also
affected, mDC and pDC were isolated from peripheral blood of
infected and uninfected individuals. Subsequently mDC were
stimulated by LPS, a TLR4 ligand and well known myeloid DC
activator, while pDC were stimulated by TLR9 ligand CpG [21].
In addition, both DC subsets were stimulated with R848 (TLR7/8
ligand), as this is a TLR ligand that can both activate mDC and
pDC. To characterize the responses of the DC subsets to the
different TLR ligands, the surface expression of maturation
markers was determined. As expected, expression of all markers
(CD40, CD80, HLA-DR and CCR7) on mDC was increased in
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increase compared to medium cultured mDC). Interestingly, the
fold increase in expression of CD80 in response to LPS and R848
and CCR7 in response to LPS was significantly lower in the
cultured mDC derived from the Schistosoma-infected group
compared to the uninfected group (Fig. 2A). The mean
fluorescence intensity (MFI) of CD80 and HLA-DR tended to
be lower on mDC derived from S. haematobium-infected subjects
after LPS stimulation and significantly lower for HLA-DR in
response to R848 (Fig. 2B). CpG and R848 induced an increase in
surface markers on pDC, but with no significant differences
between the two groups (Fig. 2C), although in absolute expression
levels, there was a tendency towards a lower CD80 expression in
the infected group following CpG stimulation (Fig. 2D).
To further characterize the TLR responsiveness of the blood
DC, several cytokines were analysed in supernatants (Fig. 2E).
LPS-stimulated mDC produced only very low levels of IL-10 and
IL-6, whereas R848 induced much more and higher cytokine
responses in mDC. Interestingly, mDC from infected subjects had
a significantly impaired IL-12 and IL-6 production in response to
R848 relative to mDC isolated from uninfected individuals. In
contrast, comparison of CpG- or R848-induced cytokine produc-
tion by pDC from the two groups revealed no differences,
including the classical pDC derived cytokines IFN-a and CXCL-
10. Taken together, these data show that mDC but not pDC from
S. haematobium-infected individuals are functionally impaired in
their responses to TLR ligands tested here in terms of upregulation
of maturation markers and cytokine expression.
Figure 1. Reduced frequencies of mDC and pDC in blood from S. haematobium-infected subjects. (A) Blood DC were identified in fixed
PBMC as HLA-DR
+/CD14
2/CD19
2 cells and subsequently subdivided into mDC and pDC on the basis of positive staining for BDCA-1 and BDCA-2,
respectively. Data from one representative donor is shown. (B) Frequencies of blood DC subsets in total PBMC (C) and their surface expression of
HLADR, CD80, CD86 and CCR7 was determined by following the gating strategy shown in (A). (B) Box and whiskers with 10–90% percentile are
shown. (C) Bars represent mean + SD. (B+C) Each group represents data from 20 donors.
doi:10.1371/journal.pntd.0000667.g001
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pro-inflammatory MAPK signaling to LPS, but not with
altered TLR4 expression
To explore the mechanisms underlying the reduced TLR
responsiveness in mDC from infected subjects, we focused on LPS
as a stimulus since triggering of TLR4 by LPS is one of the most
well characterized pathways leading to myeloid DC activation
[21]. First TLR4 expression on mDC was analysed. However, no
differences were seen in surface expression of TLR4 on mDC
between both groups (fig. 3A), suggesting that other mechanisms
underlie the observed differences in TLR4 responsiveness. TLR-
mediated DC activation is known to be mediated by signaling
molecules that include the mitogen activated protein kinases
(MAPK) p38 and ERK. Activation of p38 downstream of TLR
triggering in DC has been shown to be important for expression of
maturation markers and cytokines production, whereas ERK
phosphorylation is linked to dampening of these responses [22].
Given that schistosomal antigen preparations have been shown to
modify TLR responses through modulation of these MAPK
[19,20,23] we asked whether altered TLR signaling via p38 and
ERK could provide an explanation for the reduced TLR
responsiveness in the infected group. Phosphorylation of MAPK
p38 and ERK was determined at 20 and 60 minutes after TLR4
stimulation, timepoints at which the activation of these MAPK in
DC are known to peak following TLR engagement [20,23,24]. We
found that stimulation of mDC by LPS resulted in a higher
phosphorylated ERK/p38 ratio in the Schistosoma-infected group
compared to the controls (Fig. 3C), which was due to a tendency
towards higher ERK phosphorylation on the one hand and lower
p38 phosphorylation on other hand (Fig. 3B). These data show
that mDC from infected individuals display a reduced induction of
pro-inflammatory MAPK activation in response to LPS. These
results indicate that a change in downstream signaling, rather than
TLR4 expression itself, may be responsible for the impaired
responsiveness of mDC from S. haematobium infected individuals
towards LPS.
mDC from S. haematobium infected subjects have
impaired T cell activation capacity, due to reduced HLA-
DR expression
DC are instrumental in the priming and regulation of T cell
responses. In this process antigen presentation, costimulation and
cytokine production by DC play a crucial role. Since these
processes were affected in mDC from S. haematobium-infected
subjects, we assessed the T cell-priming capacities of these DC. To
address this, allogeneic naı ¨ve T helper cells were cocultured
together with LPS-stimulated mDC. After 6 days T cell expansion
and T cell cytokines were analysed. Interestingly, T cells primed
by mDC from Schistosoma-infected subjects had expanded signif-
icantly less than the T cells in the presence of mDC from
uninfected subjects (Fig. 4A). Schistosomes are known to condition
DC to promote Th2 and regulatory type T cell responses [2,9],
characterized by an increased production of IL-4, IL-5, IL-13 and
IL-10, respectively. Yet, total cytokine production in day 6 culture
supernatants (data not shown) or intracellular cytokines following
polyclonal restimulation (Fig. 4B) revealed no differences in T cell
polarization by mDC from infected or uninfected individuals.
However, the frequency of IL-4 or IFN-c producing T cells was
significantly lower when primed by mDC from infected subjects
compared to uninfected individuals. In contrast, the proportion of
Figure 2. mDC, but not pDC, from S. haematobium-infected subjects have impaired TLR responses. Isolated blood DC were stimulated
with 100 ng/ml LPS (mDC), 1 mg/ml R848 (mDC & pDC) or 1 mg/ml CpG (pDC) for 40 h. (A–D) LPS- and R848-matured mDC and CpG and R848
stimulated pDC were analysed for maturation marker expression by FACS. Expression of surface marker is either shown (A+C) as fold increase relative
to medium or (B+D) as absolute mean fluorescence intensity. (E) Cytokines levels in 40 h culture supernatants from TLR-stimulated DC were
determined by multiplex Luminex. Values represent cytokines concentration from which medium control cytokines levels have been subtracted.
(A+C) box plots represent 25–75 percentile range with error bars showing minimum to maximum. *, p,0,05; **, p,0,01; ***, p,0,001 for significant
differences in fold increase in maturation marker expression relative to the medium-stimulated DC. (B, D and E) Bars represent mean + SD. Each group
represents data from 20 donors, except for (E) in which R848-stimulated pDC cytokine data are represented by 4 and 5 donors for the infected and
un-infected group, respectively. ND: not detectable.
doi:10.1371/journal.pntd.0000667.g002
Figure 3. mDC from S. haematobium-infected subjects have an altered MAPK signaling, but not TLR4 expression profile. (A) TLR4
expression was analysed on mDC present in PBMC following the gating strategy as described in legend of Fig. 1. (B and C) 20 and 60 minutes after
stimulation with LPS, mDC were intracellularly stained for (B) phospophorylated p38 and ERK and (C) the ratio between p-ERK and p-p38
was determined by dividing the respective mean fluorescence intensities per sample. Each group represents data from 5 donors. (A) Bars represent
mean + SD. (B and C) box plots represent 25–75 percentile range with error bars showing minimum to maximum.
doi:10.1371/journal.pntd.0000667.g003
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addition, these T cells expressed lower levels of the activation
markers HLA-DR and CD25 [25] (Fig. 4C). This suggests, that
mDC from S. haematobium infected subjects do not drive distinct
polarized effector T helper cell responses, but seem to have a
general impairment to induce T cell activation and effector T cell
expansion.
For proper T helper cell activation and expansion, TCR
triggering (signal 1) and costimulation (signal 2) are provided by
DC through peptides/MHC class II complexes and costimulatory
molecules CD80 and CD86, respectively [26,27]. Since HLA-DR
and CD80 surface expression on mDC from infected individuals
following TLR stimulation tended to be lower compared to levels
found on mDC from uninfected subjects (Fig. 2B), we assessed
Figure 4. mDC from S. haematobium-infected subjects have a reduced T cell activating capacity due to lower HLA-DR expression. LPS
matured mDC were cocultured with allogeneic naı ¨ve T helper cells for 6 d after which (A) T cell expansion was determined with a counting chamber
and (B) Intracellular cytokine production or (C) CD25 and HLA-DR expression was assayed by FACS, 6 h after restimulation with phorbol 12-myristate
13-acetate (PMA) and ionomycin in the presence of brefeldin A for the last 2 h. (D+E) LPS-matured mDC from European controls were cocultured with
allogeneic naı ¨ve T helper cells for 6 d in the presence of depicted neutralizing antibodies and T cells were counted as in (A). T cell counts are shown
as (D) absolute values or (E) relative to the control condition. (A,B,D) Horizontal bars represent mean based on data from 9 donors in each group. (C)
Box plots represent 25–75 percentile range with error bars showing minimum to maximum based data of 9 donors in each group. (E) Bars represent
mean + SD of 3 independent experiments.
doi:10.1371/journal.pntd.0000667.g004
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could mimic their functional impairment to activate T cells.
Indeed, neutralization of HLA-DR during the DC-T cell
cocultures strongly suppressed the T cell activating capacity of
mDC as determined by T cell proliferation (Fig. 4D) and cytokine
production (data not shown). In contrast, complete blocking of
CD80 only minimally inhibited T cell expansion (Fig. 4D). This
observation, together with the fact that only minimal concentra-
tions of HLA-DR blocking antibody could already interfere with
mDC induced T cell activation (Fig. 4E), point in the direction
that the observed differences in HLA-DR expression, although
small, play a major role in the different capacity of the mDC from
infected and uninfected subjects to drive T cell activation.
Discussion
There is a wealth of evidence from both in vitro and murine
models that helminth parasites or their secreted products are able
to modulate and suppress DC function [28,29]. However, apart
from a recent report that has documented a suppressed function of
in vitro generated monocyte-derived DC isolated from hookworm
infected subjects [30], there is currently little known about the
actual consequences of chronic helminth infections on human DC
function in vivo. In the study presented here, we now provide
support for the notion that human blood DC are functionally
impaired during chronic helminth infection in vivo, by showing that
circulating mDC isolated from Schistosoma-infected subjects have
an reduced capacity to respond to TLR ligands and to initiate T
helper cell responses.
Quantification of circulating mDC and pDC in blood from
infected subjects revealed that these cells are present in reduced
frequencies as well as numbers/ml blood compared to controls.
This appears to be a phenomenon that is associated with more
chronic infections in general, since similar observations have been
made in patients with chronic Hepatitis B [31], HIV [32],
tuberculosis [33] and malaria infection [34]. The reason for lower
frequencies remains unclear, but similar to what has been
documented for microfilaria of the species Brugia malayi [35,36],
Schistosoma parasites may promote direct apoptosis in DC. An
increase in migration out of the circulation would also be a
possible explanation, since chronic Schistosoma infection may favor
migration of DC into inflamed tissues or lymphoid organs. Finally,
the output of DC from the bone marrow could be altered, since we
also observed lower monocyte, but not T cell frequencies in the
circulation of the infected individuals (unpublished data), a cell
type closely related to mDC and originating from same bone
marrow precursors [37,38].
In order to exert their function as innate immune cells, DC have
to be able to sense and respond rapidly to external stimuli,
including pathogen derived components. This is reflected in the
release of cytokines and expression of a set of membrane bound
molecules crucial for the initiation of the adaptive arm of the
immune response [27]. We found that mDC from infected subjects
displayed reduced responses towards TLR ligands LPS and R848.
The fact that all analysed cytokines, including IL-10, were lower
expressed in response to R848 by mDC from infected subjects
compared to uninfected controls, suggests that these DC don’t
have a more anti-inflammatory phenotype but instead have a
general impairment respond to TLR ligation. Furthermore, the
selective impairment to upregulate HLA-DR by mDC from
infected subjects was found after stimulation with both LPS and
R848. This suggests that the impaired response may not be TLR-
specific but rather a more general phenomenon. Impaired TLR
responsiveness of blood DC has been reported during other
chronic infections as well, where both reduced TLR expression
[39,40] as well as altered signaling [40,41] has been implicated as
underlying mechanisms. We could not observe any difference in
TLR4 expression between the two groups. However, we did find a
tendency towards lower p38 activation in mDC from the infected
group when compared to the uninfected group in response to LPS.
The fact that p38 activation in DC is important for mediating pro-
inflammatory signaling following triggering of multiple TLR [42],
may point in the direction that a general deficit of pro-
inflammatory signaling, rather than TLR expression itself,
underlies the impaired responsiveness of mDC towards TLR
ligands from S. haematobium infected individuals.
In addition to defects in innate responses of the DC, we
observed an impaired capacity of these cells to prime T cell
responses. Given that chronic Schistosoma infection is generally
associated with a Th2-like as well as anti-inflammatory immuno-
logical profile [1,2] and several in vitro studies have shown that
schistosomal antigens can drive these responses via DC [18,20,43–
45], one could hypothesize that blood DC from infected
individuals would favor the differentiation of naı ¨ve T cell towards
these subsets. However, we observed a general failure to prime and
activate a T helper cell response by mDC, reflected by reduced T
cell expansion and a general impairment in production of both
Th1 and Th2 associated cytokines after restimulation. An
explanation for this discrepancy may be provided by the current
view that only after migration into tissues blood DC receive the
right differentiation signals to acquire their full T cell polarizing
potential [46]. Alternatively, the level of potentially polarizing
factors in blood may be too low to affect the polarizing capacity of
these DC.
With regard to the mechanisms that may underlie the impaired
capacity of these DC to prime T cell responses, we found a
tendency towards lower HLA-DR as well as CD80 expression on
LPS-matured mDC derived from infected individuals. Both TCR
triggering and costimulation are instrumental for DC-mediated T
cell activation [27]. However, the fact that even partial
neutralization of HLA-DR in mDC – T cell cocultures had a
similar impact on T cell activation as total blockade of CD80,
makes it more likely that primarily the reduced HLA-DR
expression, though small, accounts for the observed differences
in T cell-activating capacity. Nonetheless, involvement of other
membrane-bound or soluble factors in the observed differences in
T cell priming cannot be excluded. A recent in vivo murine study
has shown that Schistosoma infection can lead to T cell anergy
through induction of PD-L1 on macrophages [13]. However, we
did not find any differences in expression of PD-L1 between the
mDC of the two groups (data not shown), making a role for PD-L1
in the observed differences unlikely. Thus, we conclude that
probably not an increase in negative costimulatory signals, but
most likely a lack of antigen presentation underlies the reduced
capacity of blood DC from infected individuals to prime a T cell
response.
It remains to be established what the mechanisms are that
underlie the impaired DC function in Schistosoma-infected individ-
uals. Modulation of DC function by direct interactions with
Schistosoma-derived antigens would provide a plausible explanation.
Several studies have documented potent modulatory effects of
schistosomal antigens on the function of in vitro generated DC, that
include suppression of TLR-induced cytokine production, matu-
ration marker expression and MAPK signaling [19,20,47] and
manipulation of DC-driven T cell responses [13,18,24,48]. Adult
S. haematobium worms are found in the venous plexuses around the
urinary bladder, thereby providing a physiological situation in
which circulating DC could constantly be exposed to potentially
Schistosomiasis Impairs Human mDC Function
www.plosntds.org 8 April 2010 | Volume 4 | Issue 4 | e667modulatory antigens released by these parasites in the blood. In
this respect, an interesting finding was that mDC from infected
subjects, but not pDC, were less responsive to TLR ligands.
Schistosomal antigens can be recognized by and have been shown
to exert their modulatory effects on DC through engagement of
certain TLRs, such as TLR2 [18,20] and c-type lectins like DC-
SIGN [47,49] which are preferentially expressed by myeloid, and
not the plasmacytoid DC lineage [50,51]. Apart from this direct
mechanism, chronic Schistosoma infection may also lead to
attenuation of DC function indirectly by induction of regulatory
immune responses. For instance, important regulatory cytokines
produced by the host, such as IL-10, have the potential to suppress
DC function [15] and to be elevated in S. haematobium infected
subjects [17]. Lastly, chronic schistosomiasis has also been shown
in several studies to negatively affect the nutritional status of the
host [52,53]. Although there is currently little known about the
consequences of malnutrition on the functionality of DC during
schistosomiasis, experimental models show that undernutrition as
such can lead to an impaired function of APC resulting in a
diminished induction of adaptive immune responses [54,55].
Despite the fact the infected and healthy individuals enrolled in
this study were sex and age matched and living in the same
endemic area (Table 1), we cannot formally exclude that other
environmental factors, such as co-infections, could contribute to
observed differences in DC phenotype and function. In this
respect, since filarial and malarial infections are also highly
endemic in Gabon and have been documented to modulate APC
function [40,56,57], the participants in this study were screened
for infection by these parasites. While only a single individual was
tested positive for malaria infection, several cases of filariasis were
found in both groups (Table 1). However, stratification based on
filarial infection revealed that these parasitic infections could not
account for the observed differences in DC function (data not
shown). Furthermore, other endemic chronic infections such as
HIV, hepatitis and tuberculosis, are not likely to underlie the
selective dysfunction of mDC either, since in contrast to our
findings, these types of infections have been found to be associated
with functional impairment of pDC [33,39,58,59].
In summary, the data presented in this study provide support for
the notion that chronic schistosomiasis results in suppression of
human DC function in vivo. This sheds new light on the
mechanisms that could underlie the immune hyporesponsiveness
observed during chronic helminth infections [2,14]. Importantly, a
general impairment in TLR responses of mDC and subsequent
priming of T cell responses, may not only lead to impediment of
immune responses against the worms, but may also have
consequences for proper induction of protective immunity against
concurrent infections, especially from bacterial or viral origin,
which draws heavily on TLR-driven APC activation [60]. Finally,
suppressed function of DC, as we documented here during a
chronic helminth infection, has also been documented in chronic
infections caused by other pathogens such as bacteria [33] or
viruses [31,58,59]. This suggests that an impaired DC function
during persistent infections is a widely distributed phenomenon
and points in the direction that targeting of DC is a common
strategy evolved by pathogens to subvert immune responses and
establish chronic infections.
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